PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,703,309 | +45.9% | 337,289 | +45.3% | 0.00% | – |
Q2 2023 | $1,167,720 | -42.5% | 232,151 | -29.7% | 0.00% | – |
Q1 2023 | $2,030,773 | -67.9% | 330,207 | -31.0% | 0.00% | -100.0% |
Q4 2022 | $6,320,530 | +332.3% | 478,828 | -2.8% | 0.00% | – |
Q3 2022 | $1,462,000 | -25.3% | 492,523 | -8.1% | 0.00% | – |
Q2 2022 | $1,956,000 | -11.7% | 536,017 | +49.9% | 0.00% | – |
Q1 2022 | $2,214,000 | +36.2% | 357,678 | +78.2% | 0.00% | – |
Q4 2021 | $1,625,000 | -66.6% | 200,682 | -38.5% | 0.00% | -100.0% |
Q3 2021 | $4,862,000 | +62.2% | 326,247 | +36.6% | 0.00% | – |
Q2 2021 | $2,998,000 | – | 238,914 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
AMUSSEN HUNSAKER ASSOCIATES LLC | 75,016 | $377,330 | 0.08% |
Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |